Objectives: Assessment of anti-human colon cancer cell (HT-29 cell) efficacy and activating apoptosis of MeV and MuV combination in vitro. Assessment of C cell tumor efficacy of MeV and MuV combination in nude mice xenograft models.

Study the Malondialdehyde content in patients with colon cancer who underwent radical surgery treatment. Evaluate the changes in red blood cell Malondialdehyde content of patients with colon cancer after radical surgery.